MedTrace Logo

Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese Patients

NCT02400489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2022-03-18

No results posted yet for this study

Summary

To recruit patients who implanted with Perimount Heart Valve (Type Number: 6900PTFX or 2800TFX) from three hospitals in China.

To track the patients'situations during one year after surgery and to collect the relevant clinical data.

Conditions

  • Mitral Valve or Aortic Valve Replacement

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Xufa Chen, M.D · Wuhan Asia Heart Hospital

  • Chengwei Zou, M.D · Shandong Provincial Hospital

  • Nan Jiang, M.D · Tianjin Chest Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-25
Primary Completion
2016-04-27
Completion
2020-06-03

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02400489 on ClinicalTrials.gov